Protection from pulmonary ischemia-reperfusion injury by adenosine A2A receptor activation
Reads0
Chats0
TLDR
Specific activation of A2AARs provides potent protection against lung IR injury via attenuation of inflammation, and occurs in the absence of circulating blood thereby indicating a protective role of A 2AAR activation on resident lung cells such as alveolar macrophages.Abstract:
Background: Lung ischemia-reperfusion (IR) injury leads to significant morbidity and mortality which remains a major obstacle after lung transplantation. However, the role of various subset(s) of lung cell populations in the pathogenesis of lung IR injury and the mechanisms of cellular protection remain to be elucidated. In the present study, we investigated the effects of adenosine A 2A receptor (A 2A AR) activation on resident lung cells after IR injury using an isolated, bufferperfused murine lung model. Methods: To assess the protective effects of A2AAR activation, three groups of C57BL/6J mice were studied: a sham group (perfused for 2 hr with no ischemia), an IR group (1 hr ischemia + 1 hr reperfusion) and an IR+ATL313 group where ATL313, a specific A 2A AR agonist, was included in the reperfusion buffer after ischemia. Lung injury parameters and pulmonary function studies were also performed after IR injury in A2AAR knockout mice, with or without ATL313 pretreatment. Lung function was assessed using a buffer-perfused isolated lung system. Lung injury was measured by assessing lung edema, vascular permeability, cytokine/chemokine activation and myeloperoxidase levels in the bronchoalveolar fluid. Results: After IR, lungs from C57BL/6J wild-type mice displayed significant dysfunction (increased airway resistance, pulmonary artery pressure and decreased pulmonary compliance) and significant injury (increased vascular permeability and edema). Lung injury and dysfunction after IR were significantly attenuated by ATL313 treatment. Significant induction of TNF-α, KC (CXCL1), MIP-2 (CXCL2) and RANTES (CCL5) occurred after IR which was also attenuated by ATL313 treatment. Lungs from A2AAR knockout mice also displayed significant dysfunction, injury and cytokine/ chemokine production after IR, but ATL313 had no effect in these mice. Conclusion: Specific activation of A 2A ARs provides potent protection against lung IR injury via attenuation of inflammation. This protection occurs in the absence of circulating blood thereby indicating a protective role of A2AAR activation on resident lung cells such as alveolar macrophages. Specific A 2A AR activation may be a promising therapeutic target for the prevention or treatment of pulmonary graft dysfunction in transplant patients.read more
Citations
More filters
Journal ArticleDOI
Role of inflammatory cells and adenosine in lung ischemia reoxygenation injury using a model of lung donation after cardiac death.
Hassiba Smail,Jean-Marc Baste,Hugues Begueret,Romain Noël,Jean-Paul Morin,Pierre-Yves Litzler +5 more
TL;DR: This model showed that lymphocytes increased the inflammatory response and the histological lesions after 4 h of warm ischemia and that adenosine could have an anti-inflammatory role with potential reconditioning action when used in the pneumoplegia solution.
Journal ArticleDOI
Attenuation effect of polydeoxyribonucleotide on inflammatory cytokines and apoptotic factors induced by particulate matter (PM10) damage in human bronchial cells.
Lakkyong Hwang,Il-Gyu Ko,Jun-Jang Jin,Sang-Hoon Kim,Chang-Ju Kim,Jae Joon Hwang,Cheon Woong Choi,Bok Soon Chang +7 more
TL;DR: Anti‐cytotoxicity, anti‐inflammation, and anti‐apoptosis effects of PDRN can be attributed to the adenosine A2AR enhancing effect on PM10‐exposed bronchial cells.
BookDOI
Purinergic regulation of respiratory diseases
Maryse Picher,Richard C. Boucher +1 more
TL;DR: This work focuses on the regulation of Airway Nucleotides in Chronic Lung Diseases and the role of Purinergic Signaling in Wound Healing and Airway Remodeling.
The Role of Purinergic Signalling in Inflammatory Disorders
TL;DR: The author and the views expressed in this thesis are those of the author and do not necessarily represent the views of the University of Wollongong.
Journal ArticleDOI
Isolated perfused murine lung A well characterized preparation for studying lung vascular function
Jan Herget,Milan Chovanec +1 more
TL;DR: Preparations consisting of an isolated perfused lung from small laboratory animals is useful tool to study local regulatory mechanisms in health and disease to control individual hemodynamic and ventilation parameters in well defined experimental conditions.
References
More filters
Journal ArticleDOI
Ischemia-reperfusion-induced lung injury.
TL;DR: Better understanding of the mechanisms of ischemia-reperfusion injury, improvements in the technique of lung preservation, and the development of a new preservation solution specifically for the lung have been associated with a reduction in the incidence of primary graft failure from approximately 30 to 15% or less.
Journal ArticleDOI
Molecular Approach to Adenosine Receptors: Receptor-Mediated Mechanisms of Tissue Protection
TL;DR: Novel adenosine receptor subtype-selective ligands have recently been developed that will help investigators to sort out how adenoine protects tissues from injury and to identify new therapeutic agents that hold promise for the treatment of inflammatory and ischemic diseases.
Journal ArticleDOI
Adenosine, an endogenous anti-inflammatory agent.
TL;DR: The observations reviewed here suggest that adenosine and agents that act throughadenosine are excellent candidates for development as anti-inflammatory agents.
Journal ArticleDOI
Pulmonary atelectasis: a pathogenic perioperative entity.
TL;DR: The authors discuss the effects and implications of atelectasis in the perioperative period and illustrate how preventive measures may impact outcome and the impact of atElectasis and its prevention in acute lung injury.
Journal ArticleDOI
Obliterative bronchiolitis after lung and heart-lung transplantation: An analysis of risk factors and management
Ko Bando,Irvin L. Paradis,Shari L. Similo,Hiroaki Konishi,Kanshi Komatsu,Thomas G. Zullo,Samuel A. Yousem,John M. Close,Adriana Zeevi,Rene J. Duquesnoy,Jan D. Manzetti,Robert J. Keenan,John M. Armitage,Robert L. Hardesty,Bartley P. Griffith +14 more
TL;DR: Recipients with obliterative bronchiolitis detected in the preclinical stage were significantly more likely to be in remission than recipients who had clinical disease at the time of diagnosis and results indicate that acute rejection is the most significant risk factor for development of obliteration and that obliteration responds to treatment with augmented immunosuppression when it is detected early by surveillance transbronchial biopsy.
Related Papers (5)
Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage.
Akio Ohta,Michail V. Sitkovsky +1 more